EUVIMEDEUVIMED entdecken
Crossref

The histamine H4 receptor antagonist 1-[(5-chloro-2,3-dihydro-1-benzofuran-2-yl)methyl]-4-methyl-piperazine(LINS01007) prevents the development of DSS-induced colitis in mice

Beatriz K Lippi, Gustavo A B Fernandes, Gabriela A Azevedo, Nathani G S Negreiros, Antonio W Soares, Maristella A Landgraf, João Paulo S Fernandes, Richardt G Landgraf

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Beatriz K Lippi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil. Hauptthemen laut MEDLINE: Benzofurans, Dextran Sulfate, Piperazines, Receptors, Histamine H4. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammatory bowel disease with growing incidence worldwide. Our group reported the compound 5-choro-1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazine (LINS01007) as H4R antagonist (pKi 6.2) and therefore the effects and pharmacological efficacy on a DSS-induced mice model of UC were assessed in this work. Experimental acute colitis was induced in male BALB/c mice (n = 5-10) by administering 3 % DSS in the drinking water for six days. The test compound LINS01007 was administered daily i.p. (5 mg/kg) and compared to control group without treatment. Body weight, water and food consumption, and the presence of fecal blood were monitored during 7-day treatment period. The levels of inflammatory markers (PGE2, COX-2, IL-6, NF-κB and STAT3) were also analyzed. Animals subjected to the acute colitis protocol showed a reduction in water and food intake from the fourth day (p < 0.05) and these events were prevented by LINS01007. Histological signs of edema, hyperplasia and disorganized intestinal crypts, as well as neutrophilic infiltrations, were found in control mice while these findings were significantly reduced in animals treated with LINS01007. Significant reductions in the levels of PGE2, COX-2, IL-6, NF-κB and STAT3 were observed in the serum and tissue of treated animals. The results demonstrated the significant effects of LINS01007 against DSS-induced colitis, highlighting the potential of H4R antagonism as promising treatment for this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzofuransDextran SulfatePiperazinesReceptors, Histamine H4AnimalsMaleMiceAnti-Inflammatory AgentsColitis, UlcerativeColonCyclooxygenase 2Disease Models, AnimalInterleukin-6Mice, Inbred BALB CNF-kappa BSTAT3 Transcription Factor

Stichwörter der Autor:innen

AntihistamineH(4)R antagonistInflammatory bowel diseaseUlcerative colitis

Substanzen

Anti-Inflammatory AgentsBenzofuransCyclooxygenase 2Dextran SulfateHrh4 protein, mouseInterleukin-6NF-kappa BPiperazinesReceptors, Histamine H4STAT3 Transcription Factor

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil.
  • Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil; Programa de Pós-Graduação em Medicina Translacional, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Universidade Paulista - campus Rangel, Santos, SP, Brazil.
  • Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil. Electronic address: joao.fernandes@unifesp.br.
  • Department of Pharmaceutical Sciences, Universidade Federal de São Paulo-campus Diadema, Diadema, SP, Brazil. Electronic address: rglandgraf@unifesp.br.

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Lippi, B. K., Fernandes, G. A. B., Azevedo, G. A., Negreiros, N. G. S., Soares, A. W., Landgraf, M. A., Fernandes, J. P. S., & Landgraf, R. G. (2024). The histamine H4 receptor antagonist 1-[(5-chloro-2,3-dihydro-1-benzofuran-2-yl)methyl]-4-methyl-piperazine(LINS01007) prevents the development of DSS-induced colitis in mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112128

Vancouver

Lippi BK, Fernandes GAB, Azevedo GA, Negreiros NGS, Soares AW, Landgraf MA, et al. The histamine H4 receptor antagonist 1-[(5-chloro-2,3-dihydro-1-benzofuran-2-yl)methyl]-4-methyl-piperazine(LINS01007) prevents the development of DSS-induced colitis in mice. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112128

BibTeX
@article{Lippi2024,
  author = {Lippi, Beatriz K and Fernandes, Gustavo A B and Azevedo, Gabriela A and Negreiros, Nathani G S and Soares, Antonio W and Landgraf, Maristella A and Fernandes, João Paulo S and Landgraf, Richardt G},
  title = {The histamine H4 receptor antagonist 1-[(5-chloro-2,3-dihydro-1-benzofuran-2-yl)methyl]-4-methyl-piperazine(LINS01007) prevents the development of DSS-induced colitis in mice},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112128}
}
Kostenlos starten →